CN101253140B - 双环[3.1.0]己醇的制备方法 - Google Patents
双环[3.1.0]己醇的制备方法 Download PDFInfo
- Publication number
- CN101253140B CN101253140B CN2006800284204A CN200680028420A CN101253140B CN 101253140 B CN101253140 B CN 101253140B CN 2006800284204 A CN2006800284204 A CN 2006800284204A CN 200680028420 A CN200680028420 A CN 200680028420A CN 101253140 B CN101253140 B CN 101253140B
- Authority
- CN
- China
- Prior art keywords
- epoxide
- base
- tetramethyl piperidine
- normal
- lithium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title abstract description 5
- NHPHSQKWQYLZSA-UHFFFAOYSA-N bicyclo[3.1.0]hexan-1-ol Chemical class C1CCC2(O)C1C2 NHPHSQKWQYLZSA-UHFFFAOYSA-N 0.000 title 1
- 150000002118 epoxides Chemical class 0.000 claims abstract description 16
- 229910052744 lithium Inorganic materials 0.000 claims abstract description 12
- -1 alkyl lithium Chemical compound 0.000 claims abstract description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
- 239000001257 hydrogen Substances 0.000 claims abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- RKMGAJGJIURJSJ-UHFFFAOYSA-N 2,2,6,6-Tetramethylpiperidine Substances CC1(C)CCCC(C)(C)N1 RKMGAJGJIURJSJ-UHFFFAOYSA-N 0.000 claims description 19
- YAXWOADCWUUUNX-UHFFFAOYSA-N 1,2,2,3-tetramethylpiperidine Chemical compound CC1CCCN(C)C1(C)C YAXWOADCWUUUNX-UHFFFAOYSA-N 0.000 claims description 16
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical group CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- 150000003335 secondary amines Chemical class 0.000 claims description 6
- 239000004210 ether based solvent Substances 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 238000005888 cyclopropanation reaction Methods 0.000 abstract 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000010791 quenching Methods 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- KXMTXZACPVCDMH-UHFFFAOYSA-N methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1CO KXMTXZACPVCDMH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- ANYSGBYRTLOUPO-UHFFFAOYSA-N lithium tetramethylpiperidide Chemical compound [Li]N1C(C)(C)CCCC1(C)C ANYSGBYRTLOUPO-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/56—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by isomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
一种制备式(I)的化合物的方法:该方法包括在0.05~0.75当量的仲胺碱和至少1当量的烷基锂碱存在下式(II)环氧化物的分子内环丙烷化;其中R、R1、R2和R3每一个为氢或C1-4烷基或R1和R2连接以形成C3-7环烷基或C3-7环烯基环。
Description
本发明涉及含环丙基环的双环醇的制备方法。
Hodgson等在Journal of the American Society 2004,126,8664~8665中描述了由不饱和末端环氧化物来制备双环[3.1.0]己醇。以收率为69%~81%制备了多种双环[3.1.0]己醇,其反应时间为8~20小时。通过在0℃向环氧化物中逐滴加入2,2,6,6-四甲基哌啶锂(LTMP)(2当量),该反应以立体有择的方式进行。在Hodgson等人的另一出版物上(Synthesis 2005,Practical Synthetic Procedures No 52),该反应发生于适当的氯代醇中,其假设形成了氯代醇的醇锂,其原位产生环氧化物;由此形成双环醇。在该出版物中,向氯代醇和四甲基哌啶(TMP)(2.5当量)的混合物中加入丁基锂(3.5当量)。据声明,使用较少的丁基锂或TMP对收率是有害的。不幸地,TMP为昂贵的试剂。
现已发现,使用催化量的TMP和量少得多的丁基锂化学计量可以以高收率从不饱和的末端环氧化物来制备双环[3.1.0]链烷醇。此外,实施该反应相应所需的溶剂体积比此前所描述的要小。
因此,本发明提供一种制备式(I)的化合物的方法:
该方法包括在0.05~0.75当量的仲胺碱和至少1当量的烷基锂碱存在下式(II)环氧化物的分子内环丙烷化;
其中R、R1、R2和R3彼此独立地为氢或C1-4烷基或R1和R2连接以形成C3-7环烷基或C3-7环烯基环。适合地,仲胺碱为二异丙胺或四甲基哌啶,并优选它为四甲基哌啶。便利地,烷基锂碱为丁基锂,以高于1当量存在。存在的丁基锂为1.0~1.25当量是适合的,且优选为约1.1当量。烷基锂碱用于使仲胺碱脱质子化,其继续使环氧化物脱质子化并诱导环化反应。因此优选缓慢加入烷基锂,使得在环氧化物存在下烷基锂的浓度最小化。
适合地,R、R1、R2和R3彼此独立地选自氢、甲基、乙基和异丙基,并优选都是氢。
适合地,存在0.1~0.5当量的TMP。在本发明的一个实施方案中,存在0.5当量的TMP。
通常,该反应在适合的非反应性溶剂,例如醚,诸如叔丁基甲基醚(5~50的体积并便利地为10体积)中进行。
如果需要,可原位形成环氧化物。
在本发明的一个实施方案中,在适合的溶剂,例如醚溶剂诸如叔丁基甲基醚(5~50的体积并便利地为10体积)中将环氧化物和TMP(0.5当量)混合,并将混合物冷却至便利地-20℃~5℃,而以-5℃~0℃为宜。然后加入正丁基锂或正己基锂(1.1当量),维持低温,优选为0℃或0℃以下并将反应混合物维持在该温度直至反应完全。
其它适合用于实施该反应的溶剂包括其它醚溶剂如乙醚,和脂肪烃溶剂如庚烷。另一适合的醚溶剂是THF。
当用于本文,“当量”是指每摩尔环氧化物时所用的TMP的摩尔数以及“体积”是指每千克环氧化物时所用的以升为单位的溶剂量。
通过加入稀酸,例如稀无机酸诸如稀盐酸来使该反应混合物适合地骤冷,同时维持低温,优选0℃或更低。在骤冷反应期间,pH适合地维持在4.5~7.0。然后收集有机相,并可例如用进一步稀释的酸洗涤。或者可用有机酸如乙酸来使该反应骤冷,在这种情况下可以滤出TMP的乙酸盐并将滤出液用于进一步处理。通过用适合的有机溶剂来萃取水相可进一步提高双环醇的总收率,便利地,反应所用的溶剂为例如醚,诸如叔丁基甲基醚。任选地,所述有机相可与有机萃取液混合。
用下面的实施例来举例说明本发明的方法:
实施例1
将R-(+)-环氧化物(1)(100g,1.019mol)溶于无水叔丁基甲基醚MTBE(1L)中。向该溶液中加入2,2,6,6-四甲基哌啶(71.96g,0.509mol)并使反应混合物冷却到-5℃~0℃。在4小时间加入正己基锂(在己烷中2.3M,487mL,1.121mol),保持温度在0℃以下。所得的溶液在此温度老化,直至根据气相色谱分析所有起始的环氧化物被消耗掉(大约4小时)。通过加入3N盐酸(543mL)小心骤冷反应混合物,同时维持内部温度低于0℃。将水相分离并用3N盐酸(170mL)洗涤有机相。用MTBE(500mL和250mL)反萃取混合的水层。然后将混合的有机萃取液浓缩至总体积为约450mL。根据气相色谱分析,最终的有机层包含84.8g的2(收率为86%)。
实施例2
将R-(+)-环氧化物(1)(1g,0.01mol)溶于无水叔丁基甲基醚MTBE(10mL)中。向该溶液中加入2,2,6,6-四甲基哌啶(0.72g,0.005mol)并使反应混合物冷却到-5℃~0℃。在4小时间加入正己基锂(在己烷中2.5M,8.16mL,0.002mol),保持温度在0℃以下。所得的溶液在此温度老化,直至根据气相色谱分析所有起始的环氧化物被消耗掉(大约4小时)。通过加入3N盐酸(543mL)小心骤冷反应混合物,同时维持内部温度低于0℃。将水相分离并用3N盐酸(1.7mL)洗涤有机相。用MTBE(5mL和2.5mL)反萃取混合的水层。然后将混合的有机萃取液浓缩至总体积为约4.5mL。根据气相色谱分析,最终的有机层包含0.97g的2(收率为97%)。
Claims (11)
2.根据权利要求1的方法,其中所述仲胺碱为二异丙胺或四甲基哌啶。
3.根据权利要求2的方法,其中所述仲胺碱为四甲基哌啶。
4.根据权利要求3的方法,其中存在0.1~0.5当量的四甲基哌啶。
5.根据权利要求1~4中任何一项的方法,其中所述烷基锂碱为丁基锂。
6.根据权利要求5的方法,其中存在多于1当量的丁基锂。
7.根据权利要求1~4中任何一项的方法,其中缓慢加入烷基锂使得在存在环氧化物时使烷基锂的浓度最小化。
8.根据权利要求1~4中任何一项的方法,其中R、R1、R2和R3彼此独立地选自氢、甲基、乙基和异丙基。
9.根据权利要求1的方法,其中首先将环氧化物和四甲基哌啶在适合的溶剂中混合,然后冷却该混合物并加入正丁基锂或正己基锂,同时维持0℃或0℃以下直至反应完全。
10.根据权利要求1~4中任何一项的方法,其中所述反应是在醚溶剂中进行的。
11.根据权利要求9的方法,其中所述反应是在醚溶剂中进行的。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0515926.4A GB0515926D0 (en) | 2005-08-03 | 2005-08-03 | Chemical process |
GB0515926.4 | 2005-08-03 | ||
PCT/GB2006/050227 WO2007015111A1 (en) | 2005-08-03 | 2006-08-01 | A process for the preparation of bicyclo[3.1.0]hexanols |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101253140A CN101253140A (zh) | 2008-08-27 |
CN101253140B true CN101253140B (zh) | 2012-06-13 |
Family
ID=34983980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800284204A Expired - Fee Related CN101253140B (zh) | 2005-08-03 | 2006-08-01 | 双环[3.1.0]己醇的制备方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7834222B2 (zh) |
EP (1) | EP1912924A1 (zh) |
JP (1) | JP5243955B2 (zh) |
CN (1) | CN101253140B (zh) |
AU (1) | AU2006274689B2 (zh) |
CA (1) | CA2616724C (zh) |
GB (1) | GB0515926D0 (zh) |
WO (1) | WO2007015111A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006114581A1 (en) | 2005-04-28 | 2006-11-02 | Merck Sharp & Dohme Limited | A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles |
GB0716232D0 (en) | 2007-08-21 | 2007-09-26 | Givaudan Sa | Cyclopropanation process |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19858855A1 (de) * | 1998-12-19 | 2000-06-21 | Merck Patent Gmbh | Verfahren zur Herstellung von ortho-substituierten Arylmetallverbindungen und deren Umsetzung mit Elektrophilen |
WO2006114581A1 (en) | 2005-04-28 | 2006-11-02 | Merck Sharp & Dohme Limited | A process for the preparation of tetrazolyltetrahydrocyclopentapyrazoles |
-
2005
- 2005-08-03 GB GBGB0515926.4A patent/GB0515926D0/en not_active Ceased
-
2006
- 2006-08-01 CN CN2006800284204A patent/CN101253140B/zh not_active Expired - Fee Related
- 2006-08-01 CA CA2616724A patent/CA2616724C/en not_active Expired - Fee Related
- 2006-08-01 AU AU2006274689A patent/AU2006274689B2/en not_active Ceased
- 2006-08-01 US US11/989,885 patent/US7834222B2/en not_active Expired - Fee Related
- 2006-08-01 WO PCT/GB2006/050227 patent/WO2007015111A1/en active Application Filing
- 2006-08-01 JP JP2008524593A patent/JP5243955B2/ja not_active Expired - Fee Related
- 2006-08-01 EP EP06765375A patent/EP1912924A1/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
D.M.HODGSON,et al..Intramolecular Cyclopropanation of Epichlorohydrin-Derived Unsaturated Chlorohydrins..《Synthesis》.2005,第8卷(第13期),2264-2266. * |
Also Published As
Publication number | Publication date |
---|---|
US7834222B2 (en) | 2010-11-16 |
WO2007015111A1 (en) | 2007-02-08 |
AU2006274689A1 (en) | 2007-02-08 |
GB0515926D0 (en) | 2005-09-07 |
EP1912924A1 (en) | 2008-04-23 |
CN101253140A (zh) | 2008-08-27 |
CA2616724C (en) | 2013-05-14 |
CA2616724A1 (en) | 2007-02-08 |
US20100099923A1 (en) | 2010-04-22 |
WO2007015111A8 (en) | 2007-03-29 |
JP5243955B2 (ja) | 2013-07-24 |
AU2006274689B2 (en) | 2011-11-17 |
JP2009503046A (ja) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sasai et al. | Catalytic asymmetric nitroaldol reaction using optically active rare earth BINOL complexes: investigation of the catalyst structure | |
KR100986958B1 (ko) | 광학활성 할로게노히드록시프로필 화합물 및 글리시딜화합물의 제조법 | |
US11292777B2 (en) | Method for preparing cyclic carbonate | |
CN109666792A (zh) | 一种稀土萃取剂和分离稀土钇的方法 | |
CN101253140B (zh) | 双环[3.1.0]己醇的制备方法 | |
CN110372653B (zh) | 一种硒化苯并呋喃化合物及其合成方法 | |
KR100541786B1 (ko) | (3-알콕시페닐)마그네슘 클로라이드를 사용한 알콜의 제조방법 | |
JP4073146B2 (ja) | ガリウムアルコキシドの精製方法 | |
CN103073499A (zh) | 一种萃取法制备铼离子液体的方法 | |
US20050038286A1 (en) | Manufacture of trimethylhydroquinone diacylates | |
JP6948698B2 (ja) | パラジウム・白金抽出剤、パラジウム・白金の分離方法 | |
CN113045385A (zh) | 脂肪族频那醇的合成方法 | |
CN1297875A (zh) | 4-甲氧基甲基-2,3,5,6-四氟代苯甲醇的生产方法 | |
CN110724033B (zh) | 一种无外源碱Suzuki反应制备醇的方法 | |
US9765011B2 (en) | Method for synthesising dimethyl carbonate | |
US5262080A (en) | Lithium alkoxide reagent compositions | |
JPS6130544A (ja) | 1,3,5−トリアルキル−2,4,6−トリス(3,5−ジアルキル−4−ヒドロキシベンジル)ベンゼンの製造法 | |
EP0863120A1 (en) | Process for preparing optically active alcoholic compounds | |
CN108623429B (zh) | 一种制备1,1′-联萘的方法 | |
US7501075B2 (en) | Synthesis agent containing methyllithium/lithium bromide, and process for the preparation thereof | |
CN111153826B (zh) | 一种3-乙氧基-n-对甲苯基丙酰胺的合成方法 | |
EP0129296B1 (en) | Process for the preparation of n-arylhalopyrrolidones | |
CN108659094A (zh) | 一种mycoleptodiscin A的合成方法 | |
CN115925743A (zh) | 一种制备(2-氧代-2-芳基乙基)二芳基氧化膦类化合物的方法 | |
JP2002020334A (ja) | アダマンタン骨格を有する第三級アルコールの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120613 Termination date: 20140801 |
|
EXPY | Termination of patent right or utility model |